Patents
Patents for C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
08/2001
08/15/2001CN1308072A Partially synthetic taxinane with antineoplastic activity
08/15/2001CN1069641C Taxol cleaning and purifying method
08/09/2001WO2001057033A1 C10 carbamoyloxy substituted taxanes as antitumor agents
08/09/2001WO2001057032A1 C10 ester substituted taxanes as antitumor agents
08/09/2001WO2001057031A1 C10 carbonate substituted taxanes as antitumor agents
08/09/2001WO2001057030A1 C7 carbonate substituted taxanes as antitumor agents
08/09/2001WO2001057029A1 C7 heterosubstituted acetate taxanes as antitumor agents
08/09/2001WO2001057028A1 C7 carbamoyloxy substituted taxanes as antitumor agents
08/09/2001WO2001057027A1 C7 ester substituted taxanes as antitumor agents
08/09/2001WO2001057014A2 Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
08/09/2001WO2001057013A1 Taxane formulations having improved solubility
08/09/2001WO2001056565A1 C-4 carbonate taxanes
08/09/2001WO2001056564A1 C10 heterosubstituted acetate taxanes as antitumor agents
08/09/2001US20010012852 Oxetanone compounds covelently linked with a polysacchride; lipase inhibitor
08/09/2001CA2399116A1 C-4 carbonate taxanes
08/09/2001CA2368541A1 C10 carbamoyloxy substituted taxanes as antitumor agents
08/09/2001CA2368540A1 C7 carbonate substituted taxanes as antitumor agents
08/09/2001CA2368534A1 C7 heterosubstituted acetate taxanes as antitumor agents
08/09/2001CA2368510A1 C7 carbamoyloxy substituted taxanes as antitumor agents
08/09/2001CA2368502A1 C10 heterosubstituted acetate taxanes as antitumor agents
08/09/2001CA2368151A1 C10 carbonate substituted taxanes as antitumor agents
08/09/2001CA2367661A1 Taxane formulations having improved solubility
08/08/2001EP1122044A1 Waterproofing/preservative compositions
08/08/2001EP1121857A1 Preparation of quarternary ammonium carbonates
08/07/2001US6271384 Self-assembled taxo-diterpenoid nanostructures
08/02/2001WO2001055126A2 Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin iii
08/02/2001CA2398655A1 Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin iii
08/01/2001CN1305999A Process for extracting taxol from filtrate of enqlish yew cell culturing liquid
07/2001
07/31/2001US6268381 Excellent water solubility and antitumor activity.
07/26/2001WO2001053282A1 Semi-synthetic taxanes with antitumor and antiangiogenetic activities
07/26/2001US20010009964 Catalyst for preparing lactone and a method for preparing lactone
07/25/2001EP1118325A2 Drug delivery systems containing microtubule stabilizing agents and the use of said agents in the manufacture of a medicament for treating atherosclerosis or restenosis
07/25/2001EP1117440A1 Pharmaceutical compositions containing paclitaxel
07/24/2001US6265587 Intermediary compounds for the hemisynthesis of taxanes and preparation processes therefor
07/19/2001WO2001051476A2 Production of taxol and taxanes
07/19/2001CA2395573A1 Production of taxol and taxanes
07/18/2001EP1116718A2 Method for the preparation of taxol and its derivatives
07/17/2001US6262281 Anticancer agent
07/17/2001US6261813 Two step enzymatic acylation
07/17/2001CA2307548C Process for converting 9-dihydro-13-acetylbaccatin iii into taxol and derivatives thereof
07/17/2001CA2119363C 10-desacetoxytaxol derivatives
07/11/2001EP1114815A2 Process to prepare taxol
07/11/2001EP1114704A2 Waterproofing/preservative compositions
07/11/2001EP0758231B1 Taxane class derivative based pharmaceutical compositions
07/11/2001CN1068320C Process for making alkylene oxide
07/05/2001US20010006962 Behavior of biologically active compounds favorably modified by replacing a functional group with an unsaturated fatty derivative, e.g. elaidic acid; bioavailability; membrane passage; organ targeting; drugs; agriculture
07/04/2001CN1067997C Process for preparing propionitaxiene -13 alpha ester trihydrate
07/04/2001CN1067996C Method for preparing propionitaxiene ester trihydrate
07/04/2001CN1067973C Process for chlorohydrin tubular reaction
06/2001
06/28/2001WO2001002407A3 Taxane derivatives and processes for the preparation thereof
06/27/2001EP1109798A1 Geranic acid derivatives
06/27/2001EP1109547A1 New use of taxoid derivatives
06/27/2001CN1067682C Anti-tumor compounds, pharmaceutica compositions, methods for preparation thereof and for treatment.
06/26/2001US6252094 Using onium salt in aqueous solvent
06/20/2001EP1108717A2 C7 taxane derivatives and pharmaceutical compositions containing them
06/20/2001EP1108716A2 C7 taxane derivatives and pharmaceutical compositions containing them
06/20/2001CN1300289A Novel cephalotaxane derivatives and process for their preparation
06/19/2001US6248908 Process for the preparation of a paclitaxel C-4 methyl carbonate analog
06/13/2001EP1105380A1 Process for the preparation of c-4 deacetyltaxanes
06/13/2001EP1105379A1 Water soluble analogs and prodrugs of paclitaxel
06/13/2001EP1105119A2 New use of taxoid derivatives
06/13/2001EP1105118A1 Halogenated paclitaxel derivatives
06/13/2001CN1299355A Method and useful intermediates for paclitaxel synthesis from C-7, C-10 Di-CBZ Baccatin III
06/13/2001CN1298876A Process for preparing epoxy chloropropane by catalytic epoxidation of chloropropene by molecular oxygen
06/13/2001CN1298759A Catalyst for preparing gamma-butyrolactone from cis-aldehyde by ordinary-pressure gas-phase hydrogenation and its use
06/05/2001US6242615 Amidation of acid containing compounds; useful in inhibiting tumor necrosis factor and metalloproteinases
06/05/2001US6242614 10-deacetylbaccatin-iii which is protected at the 7-position with a dialkylalkoxysilyl protecting group; antitumor agents
05/2001
05/31/2001WO2001038318A1 Cytotoxic agents comprising taxanes and their therapeutic use
05/31/2001US20010002423 Oxetane compound, oxetane copolymer, and process for producing the oxetane compound
05/29/2001US6239237 Group 8, 9 or 10 transition metal catalyst for olefin polymerization
05/29/2001US6239167 Antitumor compositions containing taxane derivatives
05/23/2001CN1066151C Prodrugs of pacolitaxel derivatives
05/23/2001CN1066144C Process for the preparation of 7-hydroxy taxanes
05/22/2001US6235787 Antiinflammatory agents; rheumatic diseases; bone disorders; skin disorders; multiple sclerosis
05/22/2001US6235305 Drugs as enzyme inhibitors, polysaccharide polymer supports and bonds noncleavable by digestion
05/17/2001WO2001034589A1 Semi-synthesis of baccatin iii from 9-dihydro-13-acetylbaccatin iii
05/17/2001WO2000078741A3 Process for extraction and purification of paclitaxel from natural sources
05/17/2001CA2389702A1 Semi-synthesis of baccatin iii from 9-dihydro-13-acetylbaccatin iii
05/16/2001EP0941089B1 Use of anti-microtubule agents for treating or preventing multiple sclerosis
05/15/2001US6232477 Methods of preparing new taxoids and pharmaceutical compositions containing them
05/10/2001WO2001032670A1 Oxetanone derivatives
05/10/2001WO2001032669A1 Oxetanone derivatives
05/10/2001WO2001032616A2 Oxetanone derivatives
05/10/2001CA2358921A1 Oxetanone derivatives
05/09/2001EP0749432B1 9-deoxotaxane compounds
05/09/2001CN1294578A Novel naphthyl-substituted and anilide-substituted sulfonanides
05/08/2001US6229027 Process for manufacturing paclitaxel and 13-acetyl-9-dihydrobaccatin IV
05/03/2001WO2001030770A1 Stereoselective synthesis of oxazoline derivative
05/02/2001EP1095938A1 Oxetane compounds, oxetane copolymer, and process for producing oxetane compounds
05/02/2001CN1065240C Taxanes having butenyl substituted side-chain and pharmaceutical compositions containing them
05/01/2001US6225463 Reacting s-amine compound with an aldehyde; reacting with acyl chloride in presence of triethylamine to form diastereoisomeric beta-lactams; separation; treating with cerium ammonium nitrate and acetonitrile and water
04/2001
04/25/2001EP1093811A1 Anti-tumor compositions containing taxan derivatives
04/25/2001CN1064958C Method for preparation of taxol midbody
04/24/2001US6222053 Protecting hydroxy group at 7-position of 9-dihydro-13-acetylbaccatin iii; oxidizing hydroxy group at 9-position of 9-dihydro-13-acetylbaccatin iii; deacylating ester at 13-position to form a 13-hydroxy
04/24/2001US6221153 Dissolving compound selected from taxoid or brystatin in solvent; mixing with critical, supercritical or near critical fluid to form solution comprising fluid solvent and compound; precipitating compound as needle like crystal
04/19/2001WO2001027115A1 Pentacyclic taxane compounds
04/18/2001EP1092433A2 Compositions and methods for treating or preventing inflammatory diseases
04/17/2001US6218553 Process for the preparation of taxane derivatives and β-lactam intermediates therefor
04/12/2001WO2001025223A1 Stabilization of taxane-containing dispersed systems
04/12/2001WO2001024926A1 Olefin epoxidation catalysts
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 55